Lifeward Ltd. (LFWD) Stock Analysis & Investment Frameworks
Lifeward Ltd. (LFWD) stock analysis on Invetso. Review Lifeward Ltd.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
Lifeward Ltd. Company Overview
- Exchange: NASDAQ Capital Market
- Sector: Healthcare
- Industry: Medical - Devices
- Country: IL
Lifeward Ltd. Key Financial Metrics
- Market Cap: $8.86M
- Revenue: $22.03M
- ROE: -310.86%
- ROIC: -92.39%
- Dividend Yield: N/A
About Lifeward Ltd.
Lifeward Ltd. is a healthcare technology company specializing in the creation, development, and commercialization of wearable robotic exoskeletons. These sophisticated devices are engineered to restore lower limb mobility for individuals living with spinal cord injuries (SCI), granting them the ability to stand, walk, pivot, and navigate staircases by providing assistive hip and knee motion. Key offerings from the company include the ReWalk Exo-Suit and the ReWalk Personal 6.0. Founded by Amit Goffer on June 20, 2001, the enterprise maintains its corporate headquarters in Marlborough, Massachusetts.
Lifeward Ltd. Investment Frameworks
Invetso analyzes Lifeward Ltd. (LFWD) across the following frameworks:
- Lifeward Ltd. 10Y Growth Potential
- Lifeward Ltd. Scenario Analysis
- Lifeward Ltd. Risks & Opportunities
- Lifeward Ltd. Economic Moat
- Lifeward Ltd. Business Model
- Lifeward Ltd. Management
- Lifeward Ltd. SWOT Analysis
- Lifeward Ltd. Porter's 5 Forces
- Lifeward Ltd. PESTLE Analysis
- Lifeward Ltd. ESG Analysis